JPS497237A - - Google Patents

Info

Publication number
JPS497237A
JPS497237A JP48041750A JP4175073A JPS497237A JP S497237 A JPS497237 A JP S497237A JP 48041750 A JP48041750 A JP 48041750A JP 4175073 A JP4175073 A JP 4175073A JP S497237 A JPS497237 A JP S497237A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP48041750A
Other languages
Japanese (ja)
Other versions
JPS5825656B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS497237(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of JPS497237A publication Critical patent/JPS497237A/ja
Publication of JPS5825656B2 publication Critical patent/JPS5825656B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP48041750A 1972-04-12 1973-04-12 ドパミンユウドウタイ ノ セイゾウホウ Expired JPS5825656B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (2)

Publication Number Publication Date
JPS497237A true JPS497237A (fr) 1974-01-22
JPS5825656B2 JPS5825656B2 (ja) 1983-05-28

Family

ID=22918877

Family Applications (2)

Application Number Title Priority Date Filing Date
JP48041750A Expired JPS5825656B2 (ja) 1972-04-12 1973-04-12 ドパミンユウドウタイ ノ セイゾウホウ
JP57149025A Granted JPS58131945A (ja) 1972-04-12 1982-08-27 第二アミン化合物およびその塩の製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP57149025A Granted JPS58131945A (ja) 1972-04-12 1982-08-27 第二アミン化合物およびその塩の製造方法

Country Status (31)

Country Link
JP (2) JPS5825656B2 (fr)
KR (1) KR790000113B1 (fr)
AR (1) AR203822A1 (fr)
AT (1) AT323719B (fr)
AU (1) AU472734B2 (fr)
BE (1) BE798051A (fr)
BG (1) BG23001A3 (fr)
CA (1) CA1018188A (fr)
CH (2) CH569691A5 (fr)
CS (2) CS190406B2 (fr)
CY (1) CY963A (fr)
DD (1) DD107670B3 (fr)
DE (1) DE2317710C2 (fr)
DK (1) DK142750C (fr)
ES (1) ES413639A1 (fr)
FR (1) FR2182947B1 (fr)
GB (1) GB1392674A (fr)
HK (1) HK50178A (fr)
HU (2) HU167597B (fr)
IE (1) IE37511B1 (fr)
IL (1) IL42016A (fr)
KE (1) KE2870A (fr)
MY (1) MY7800381A (fr)
NL (1) NL174459C (fr)
PH (1) PH11041A (fr)
PL (2) PL90695B1 (fr)
RO (2) RO65105A (fr)
SE (1) SE399064B (fr)
SU (1) SU496719A3 (fr)
YU (2) YU36483B (fr)
ZA (1) ZA732136B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (fr) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
ZA825227B (en) * 1981-07-22 1984-03-28 Syntex Inc Substituted pyrrolidine cardiovascular system regulators antihypertensives
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
ZA881076B (en) * 1987-02-24 1989-10-25 Lilly Co Eli Dobutamine salts
JPH0383364U (fr) * 1989-12-18 1991-08-23
AU658188B2 (en) * 1991-05-20 1995-04-06 Tsumura & Co. Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient
ATE155125T1 (de) * 1993-04-13 1997-07-15 Duphar Int Res Herstellung von dobutamin verbindungen
EP0620208B1 (fr) * 1993-04-13 1997-07-09 Duphar International Research B.V Production de composés de la dobutamine
WO2004031129A2 (fr) 2002-10-03 2004-04-15 New Era Biotech, Ltd. Nouveaux composes destines au traitement des maladies auto-immunes, des maladies immuno-allergiques et des rejets en cas de greffes d'organes ou de tissus
CA2560922C (fr) 2004-03-26 2014-01-07 New Era Biotech, Ltd. Ameliorations apportees a des composes destines a etre utilises dans le traitement du sida ou d'autres maladies virales et infections associees au vih et compositions contenant ces composes, methodes de traitement de ces maladies et de ces infections et methodes de fabrication de ces composes et de ces compositions
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
US9192585B2 (en) 2009-07-31 2015-11-24 Cognition Therapeutics, Inc. Inhibitors of cognitive decline
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
EP2747759A4 (fr) * 2011-08-25 2015-05-13 Cognition Therapeutics Inc Compositions et méthodes pour le traitement de maladies neurodégénératives
AU2015210852B2 (en) 2014-01-31 2019-01-24 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
DK3634394T3 (da) 2017-05-15 2026-03-02 Cognition Therapeutics Inc Sammensætninger til behandling af neurogenerative sygdomme
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 一种盐酸多巴酚丁胺的制备方法
CN117326958B (zh) * 2023-09-21 2025-07-11 锦州奥鸿药业有限责任公司 一种高纯度盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
DK142750C (da) 1981-08-17
NL174459C (nl) 1984-06-18
CA1018188A (en) 1977-09-27
PH11041A (en) 1977-10-25
BE798051A (fr) 1973-10-11
AT323719B (de) 1975-07-25
AU5438573A (en) 1974-10-17
IE37511B1 (en) 1977-08-03
JPS58131945A (ja) 1983-08-06
YU36483B (en) 1984-02-29
KR790000113B1 (en) 1979-03-20
HU167597B (fr) 1975-11-28
HK50178A (en) 1978-09-15
RO65105A (fr) 1980-01-15
DD107670B3 (de) 1988-04-06
CS190406B2 (en) 1979-05-31
MY7800381A (en) 1978-12-31
IL42016A (en) 1976-05-31
CH580563A5 (fr) 1976-10-15
CY963A (en) 1978-12-22
YU321279A (en) 1983-04-27
GB1392674A (en) 1975-04-30
HU166213B (fr) 1975-02-28
DK142750B (da) 1981-01-12
JPS6221343B2 (fr) 1987-05-12
NL7305097A (fr) 1973-10-16
ZA732136B (en) 1974-03-27
JPS5825656B2 (ja) 1983-05-28
RO70892A (fr) 1982-02-26
NL174459B (nl) 1984-01-16
AR203822A1 (es) 1975-10-31
ES413639A1 (es) 1976-01-16
CH569691A5 (fr) 1975-11-28
DE2317710C2 (de) 1983-08-04
KE2870A (en) 1978-09-01
DE2317710A1 (de) 1973-10-18
PL90695B1 (fr) 1977-01-31
YU37113B (en) 1984-08-31
BG23001A3 (bg) 1977-05-20
FR2182947A1 (fr) 1973-12-14
CS190448B2 (en) 1979-05-31
IL42016A0 (en) 1973-06-29
YU97673A (en) 1982-02-25
DD107670A5 (de) 1974-08-12
SU496719A3 (ru) 1975-12-25
SE399064B (sv) 1978-01-30
FR2182947B1 (fr) 1976-07-02
AU472734B2 (en) 1976-06-03
PL94207B1 (fr) 1977-07-30

Similar Documents

Publication Publication Date Title
FR2182947B1 (fr)
JPS5242068B2 (fr)
JPS5327483Y2 (fr)
CS158170B2 (fr)
JPS4935070A (fr)
JPS4929994A (fr)
JPS4975836U (fr)
JPS5225716Y2 (fr)
JPS4975856U (fr)
CS154090B1 (fr)
CS161013B1 (fr)
CS151840B1 (fr)
CS174317B1 (fr)
CS156971B1 (fr)
CS170922B1 (fr)
CS160339B1 (fr)
CH588722A5 (fr)
CH585385A5 (fr)
AU480295A (fr)
BG17866A1 (fr)
CH568307A5 (fr)
CH568124A5 (fr)
CH576549B5 (fr)
CH592161A5 (fr)
CH568120A5 (fr)